Development
Microbot Medical Inc.
MBOT
$2.92
$0.051.74%
NASDAQ
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -2.82% | -26.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.47% | -20.38% | |||
| Operating Income | -9.47% | 20.38% | |||
| Income Before Tax | -6.95% | 19.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.95% | 19.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.95% | 19.84% | |||
| EBIT | -9.47% | 20.38% | |||
| EBITDA | -9.83% | 20.59% | |||
| EPS Basic | 15.97% | 30.17% | |||
| Normalized Basic EPS | 15.96% | 30.16% | |||
| EPS Diluted | 15.97% | 30.17% | |||
| Normalized Diluted EPS | 15.96% | 30.16% | |||
| Average Basic Shares Outstanding | 27.27% | 14.79% | |||
| Average Diluted Shares Outstanding | 27.27% | 14.79% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||